Analyse produit facultative
Avec votre autorisation, nous utilisons une analyse limitée et respectueuse de la vie privée pour comprendre les parcours de recherche utiles. Nous n’utilisons ni traceurs publicitaires ni enregistrement de session. Vous pouvez modifier ce choix dans les préférences. Consultez la Politique de confidentialité.
The Hartford Insurance Group, Inc.'s published Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $34.1B | |
|---|---|---|
| Revenue (ttm) | 29.6B | |
| Net income (ttm) | 4.6B | |
| EPS (ttm) | $16.5 | |
| Shares out | 267.4M | |
| P/E (trailing) | 7.9x | |
| P/E (forward) | 9.2x | |
| Dividend | $2.68 (2.06%) | |
| Volume | 2,400,079 | |
| Beta | 0.49 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $1.57B | $1.42B | $1.38B | $1.46B | $1.51B | -1.0% |
| Gross profit | $2.47B | $2.05B | $3.17B | $3.97B | $13.02B | +51.5% |
| Operating income | $2.91B | $2.26B | $3.09B | $3.85B | $4.96B | +14.3% |
| Net income | $2.37B | $1.82B | $2.50B | $3.11B | $3.84B | +12.8% |
| EPS (diluted) | $6.64 | $5.46 | $7.97 | $10.35 | $13.32 | +19.0% |
| EBITDA | $3.59B | $2.89B | $3.60B | $4.21B | $5.36B | +10.6% |
| R&D | — | — | — | — | — | — |
| SG&A | $4.79B | $4.84B | $4.88B | $5.26B | $5.58B | +3.9% |
Recent company headlines from major financial publishers.
The modal path reflects steady commercial underwriting execution, with small commercial pricing remaining disciplined while middle market pricing tracks loss inflation. Employee benefits continues to deliver stable cash returns near its long-term target margin, and personal lines heads toward gradual recovery through expanded agency distribution. Intrinsic value converges toward $164.10 with an estimated probability of 55.0% and an implied return of 30.2%.
Under the upside scenario, commercial lines renewal pricing accelerates further above loss-cost trends, allowing middle and large commercial accounts to expand underwriting profitability while personal auto rate filings successfully restore personal lines margins. Reinvestment yields on fixed maturities expand net investment income, propelling earnings to the bull target of $297.95 with an estimated probability of 20.0% and an implied return of 136.4%.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 6.5% | $176 | $181 | $186 | $192 | $199 |
| 7.0% | $166 | $170 | $174 | $178 | $183 |
| 7.5% | $158 | $161 | $164 | $168 | $172 |
| 8.0% | $151 | $153 | $156 | $159 | $162 |
| 8.5% | $145 | $147 | $149 | $152 | $154 |
Upcoming earnings date and setup when available.
La notation portée par l'édition de recherche publiée chaque mois. Une notation compare le cours à la date d'analyse à la juste valeur ; elle n'indique pas si l'appréciation s'est révélée juste.
| Année | janv. | févr. | mars | avr. | mai | juin | juil. | août | sept. | oct. | nov. | déc. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
